Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 74 of the 77 references it cites were found in a registry or an index; 3 of the 41 sources its claims cite were checked for support.

Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance

Open access
Park, Yongsoon, Harris, William S. · 2003 · Journal of Lipid Research

Abstract

Omega-3 fatty acids (FAs) reduce postprandial triacylglycerol (TG) concentrations. This study was undertaken to determine whether this effect was due to reduced production or increased clearance of chylomicrons. Healthy subjects (n = 33) began with a 4-week, olive oil placebo (4 g/d) run-in period. After a 4-week wash-out period, subjects were randomized to supplementation with 4 g/d of ethyl esters of either safflower oil (SAF), eicosapentaenoic acid (EPA), or docosahexaenoic acid (DHA) for 4 weeks. Results for EPA and DHA were similar, and therefore the data were combined into one omega-3 FA group. Omega-3 FA supplementation reduced the postprandial TG and apolipoprotein B (apo B)-48 and apoB-100 concentrations by 16% (P = 0.08), 28% (P < 0.001), and 24% (P < 0.01), respectively. Chylomicron TG half-lives in the fed state were reduced after omega-3 FA treatment (6.0 +/- 0.5 vs. 5.1 +/- 0.4 min; P < 0.05), but not after SAF (6.9 +/- 0.7 vs. 7.1 +/- 0.7 min). Omega-3 FA supplementation decreased chylomicron particle sizes (mean diameter; 293 +/- 44 vs. 175 +/- 25 nm; P < 0.01) and increased preheparin lipoprotein lipase (LPL; 0.6 +/- 0.1 vs. 0.9 +/- 0.1 micromol/h/ml; P < 0.05) activity during the fed state, but had no effect on postheparin LPL or hepatic lipase activities. The results suggest that omega-3 FA supplementation accelerates chylomicron TG clearance by increasing LPL activity, and that EPA and DHA are equally effective.

Overview

CoChat Summary

TL;DR

In healthy adults, 4 weeks of EPA or DHA supplementation accelerated fed-state chylomicron triglyceride clearance and increased preheparin lipoprotein lipase activity, with EPA and DHA showing similar effects. The authors conclude that omega-3 fatty acids reduce postprandial lipemia mainly by increasing LPL-mediated chylomicron TG clearance rather than by reducing chylomicron production.

Key findings

Omega-3 supplementation reduced postprandial TG, apoB-48, and apoB-100 concentrations by 16% (P = 0.08), 28% (P < 0.001), and 24% (P < 0.01), respectively. Fed-state chylomicron TG half-lives were shorter after omega-3 treatment (6.0 ± 0.5 vs. 5.1 ± 0.4 min; P < 0.05) but not after safflower oil (6.9 ± 0.7 vs. 7.1 ± 0.7 min); fasting half-lives were unaffected. Chylomicron mean diameter decreased (293 ± 44 vs. 175 ± 25 nm; P < 0.01), and fed-state preheparin LPL activity increased (0.6 ± 0.1 vs. 0.9 ± 0.1; P < 0.05; units as reported), while postheparin LPL and hepatic lipase activities did not change significantly. EPA and DHA results were similar and were combined into one omega-3 group.

Methods

Randomized, double-blind, parallel-group, placebo-controlled study in 33 healthy subjects (11 per group: safflower oil, EPA, or DHA). After a 4-week olive oil placebo run-in and 4-week wash-out, subjects received 4 g/d ethyl esters of safflower oil, EPA, or DHA for 4 weeks. Outcomes included oral fat tolerance tests, intravenous fat clearance tests using a [3H]triolein-labeled lipid emulsion, heparin tests for lipase activity, and ANCOVA controlling for baseline values.

Limitations

The paper states that non-LPL-mediated clearance by tissues such as spleen, muscle, adipose tissue, or kidney cannot be excluded, and that it cannot rule out the possibility that omega-3 supplementation caused the intestine to secrete smaller chylomicrons. It also notes that the mechanism responsible for increased LPL activity requires further investigation. Evident from the text: the sample was small (n = 33 total, 11 per group), participants were healthy/normolipidemic, and the intervention was short (4 weeks), which limits generalizability to hypertriglyceridemic or clinical populations.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1194/jlr.m200282-jlr200

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Image 1
CC-BY · From the PDF
Image 2
CC-BY · From the PDF
Image 3
CC-BY · From the PDF
Image 4
CC-BY · From the PDF
Fig. 6 Clearance curves of [ 3 H]triolein-labeled lipid emulsion from chylomicron fraction measured during the fed state (each point is the average of three tests administered at 5, 6, and 7 h of constant feeding). Subject numbers and symbols as in Fig. 2.
Fig. 6 Clearance curves of [ 3 H]triolein-labeled lipid emulsion from chylomicron fraction measured during the fed state (each point is the average of three tests administered at 5, 6, and 7 h of constant feeding). Subject numbers and symbols as in Fig. 2.CC-BY · From the PDF
Fig. 7 The relationship between chylomicron TG half-lives and plasma TG concentration during the fasting (top) and the fed (bottom) states at the end of the placebo phase. P < 0.001 for both. n = 33.
Fig. 7 The relationship between chylomicron TG half-lives and plasma TG concentration during the fasting (top) and the fed (bottom) states at the end of the placebo phase. P < 0.001 for both. n = 33.CC-BY · From the PDF
Fig. 8 Preheparin lipoprotein lipase activities during the fasting (top) and the fed (bottom) states. Open bars, placebo; filled bars, active treatment. Values are mean ± SEM. Subject numbers are as in Fig. 2. Abbreviations as in Fig. 1. * P < 0.05 comparing the change in the SAF group to the change in the EPA and DHA groups.
Fig. 8 Preheparin lipoprotein lipase activities during the fasting (top) and the fed (bottom) states. Open bars, placebo; filled bars, active treatment. Values are mean ± SEM. Subject numbers are as in Fig. 2. Abbreviations as in Fig. 1. * P < 0.05 comparing the change in the SAF group to the change in the EPA and DHA groups.CC-BY · From the PDF

Verification

Claims the paper makes

1 Valid · 0 Not valid · 20 Not checked · 48 Own results and interpretations

29 more claims

Create a free account to see all 69 claims and to verify the 38 references still open.

See all claims — free account
  • It may state two separate claims as one. 23
  • Probably not a substantial claim. 16

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 77 references

Research works printed but not linked: 1

  1. Harris, 1991, N-3 fatty acid supplements reduce chylomicron levels in healthy volunteers, J. Appl. Nutr., 43, 5

Cited by

See all 348

Metadata

Authors
Park, Y., & Harris, W. S.
Affiliations
Saint Luke's Hospital (US)
Corresponding author
Harris, William S.
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2003-03
Volume
44
Issue
3
Pages
455-463
ISSN
0022-2275 (ISSN-L)
OpenAlex
W2028676438
Cited by
348
References
77
Citations by year
2026: 5 · 2025: 8 · 2024: 9 · 2023: 14 · 2022: 17 · 2021: 17 · 2020: 16 · 2019: 13 · 2018: 14 · 2017: 12 · 2016: 16 · 2015: 19 · 2014: 13 · 2013: 23 · 2012: 10
FWCI
10.29
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Lipid Research (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • American Heart Association
  • National Institutes of Health (5r01hl047468-04)
  • National Heart, Lung, and Blood Institute (HL-47468)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Keywords
omega-3 fatty acids, postprandial triglycerides, eicosapentaenoic acid, docosahexaenoic acid, apolipoprotein B-48, apolipoprotein B-100, lipoprotein lipase, hepatic lipase
MeSH terms
Administration, Oral, Adult, Aged, Apolipoproteins B, Cholesterol, Chylomicrons, Double-Blind Method, Fasting, Fat Emulsions, Intravenous, Female, Half-Life, Heparin, Humans, Lipoprotein Lipase, Male, Metabolic Clearance Rate, Middle Aged, Safflower Oil, Triglycerides, Fatty Acids, Omega-3, Postprandial Period, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-27, under version 3 of the claim definition (prompt extract-v3).

A second model labelled each claim on 2026-09-27 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. https://app.cochat.ai/papers/10.1194/jlr.m200282-jlr200
The paper
Park, Y., & Harris, W. S. (2003). Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. Journal of Lipid Research. https://doi.org/10.1194/jlr.m200282-jlr200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.